Aquestive Therapeutics, Inc. · NASDAQ:AQST
BlackRock, Inc. reported a 5.30% stake in Aquestive Therapeutics, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Oct 17, 2025
BlackRock, Inc. reported a 5.30% stake in Aquestive Therapeutics, Inc., 6,426,343 shares, as a passive investor on Sep 30, 2025. Filed Oct 17, 2025 (Schedule 13G/A).
- Stake
- 5.30%
- Shares
- 6,426,343
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.30% | 6,426,343 |
Source
Related
- Aquestive Therapeutics, Inc.
- BlackRock, Inc.
- Aquestive Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Barber Daniel · Oct 16, 2026
- Schedule 13G · Bass Edward P · Oct 7, 2026
- Schedule 13G/A · Bratton Douglas K · Oct 7, 2026
- Form 4 · Barber Daniel · Sep 16, 2026
- Form 4 · Korczynski Sherry · Sep 11, 2026